Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | total n=
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | total n=
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1052 984
Bimekizumab 165 0
Brodalumab 518 0
Certolizumab 184 0
Efalizumab 35 0
Etanercept 311 70
Golimumab 25 0
Guselkumab 1294 0
Infliximab 102 1
Ixekizumab 827 0
Risankizumab 1015 0
Secukinumab 1808 0
Tildrakizumab 1036 0
Ustekinumab 765 0
Apremilast 693 0
Ciclosporin 402 0
Fumaderm® 2689 0
Skilarence® 2891 0
Methotrexat 3897 0
Tofacitinib 2 0
other systemics 354 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | total n=
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | total n=
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers